Updated Research Criteria for Clinical Trials Across the Alzheimer’s Disease Continuum

Central Nervous System (CNS)

This article describes the implications of the 2017 National Institute of Aging and Alzheimer’s Association (NIA-AA) common research framework proposed to help investigators establish a research agenda and evaluate the impact of various therapeutics in the Alzheimer’s disease (AD) continuum, and specifically to define and stage AD and facilitate research reporting.